Research Papers

25 of 2979 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case repor…
Huang F; Ruan Y; He X; Lian H; Yang J.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and …
Chowdhury A; Vivanco-Suarez J; Teferi N; Belzer A; Al-Kaylani H; Challa M; Lee S; Buatti JM; Hitchon P.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic value of the systemic immune-inflammation index in patients with upper tract urothelial carcinoma after radi…
Luo Z; Yan Y; Jiao B; Huang T; Liu Y; Chen H; Guan Y; Ding Z; Zhang G.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Influences of comorbidities on perioperative rehabilitation in patients with gastrointestinal cancers: a retrospective …
Seriu N; Tsukamoto S; Ishida Y; Yamanaka N; Mano T; Kobayashi Y; Sajiki-Ito M; Inagaki Y; Tanaka Y; Sho M; Kido A.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carci…
Guo YL; Guo JX; Zhao JG; Bao YN.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The efficacy and safety of anti-EGFR target agents in patients with potentially resectable metastatic colorectal cancer…
Wang Y; Li X; Huang T; Wang D; He Y; Wei M; Chen Y; Zheng M; Shi Y; Zhang J.
World J Surg Oncol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Surgery for stage IIB-IIIB small cell lung cancer.
Huang Z; Liu Y; Wang S; Ai K; Zhang P.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nat…
van de Vlasakker VCJ; van Erning FN; Lurvink RJ; de Hingh IHJT; Nienhuijs SW.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Spectrum of malignant scalp tumours and its impact on management-a tertiary care cancer centre experience.
Varghese BT; Nadarajan AR; Thomas S; Iype EM; George NA; K M JK; Lal SS; Somanathan T.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effect of open versus video-assisted thoracoscopy on perioperative outcomes and survival for cases of thymic carcinomas…
Li G; Chang H; Wang Z; He D; Qu L; Shao Q; Wang Q.
World J Surg Oncol (Unknown)
Published: 2023
2/6 Transparent
Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Lu X; Yao Y; Ma Y; Zhang X; Peng H; Pei Y; Lu Y; Wang L.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations fo…
Chen YY; Lin KH; Kuo YS; Tsai YM; Huang HK; Huang TW.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer.
Gao H; Ji K; Bao L; Chen H; Lin C; Feng M; Tao L; Wang M.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis an…
Zeng LP; Qin YQ; Lu XM; Feng ZB; Fang XL.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prediction of pulmonary metastasis in esophageal carcinoma patients with indeterminate pulmonary nodules.
Chen M; Wang H; Huang Y; Guo F; Zheng W; Chen C; Zheng B.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Preservation vs. dissection of inferior pulmonary ligament for thoracoscopic upper lobectomy: a prospective randomized …
Qian J; Cai S; Lin P; Chi W; Chen C; Xu G; Xu C; Wu W; Zheng W; Zheng B.
World J Surg Oncol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profile…
He C; Huang Q; Zhong S; Chen LS; Xiao H; Li L.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matc…
Esswein K; Ninkovic M; Gasser E; Barenberg L; Perathoner A; Kafka-Ritsch R.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunother…
Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive factors and repetition numbers for intraoperative additional resection of initially involved soft tissue res…
Ooms M; Ponke L; Winnand P; Heitzer M; Peters F; Steiner T; Hölzle F; Modabber A.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tiss…
Yuan J; Liu K; Zhang Y; Yang Y; Xu H; Han G; Lyu H; Liu M; Tan W; Feng Z; Gong H; Zhan S.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of proteome and post-translational modifications of 2-hydroxyisobutyrylation reveals the glycolysis pathway in…
Chen S; Li D; Zeng Z; Zhang W; Xie H; Tang J; Liao S; Cai W; Liu F; Tang D; Dai Y.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effect of perioperative goal-directed fluid therapy on postoperative complications after thoracic surgery with one-lung…
Li X; Zhang Q; Zhu Y; Yang Y; Xu W; Zhao Y; Liu Y; Xue W; Fang Y; Huang J.
World J Surg Oncol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lym…
Liu X; Liu Z; Li C; Song X; Wang X; Li S; Yu Z.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management strategy and outcomes of sacrococcygeal teratoma - an Egyptian multicenter experience.
Elgendy A; AbouZeid AA; El-Debeiky M; Mostafa M; Takrouney MH; Abouheba M; Khairi A; Shehata S; Shehata SM.
World J Surg Oncol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared